NCT00175019 Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 Status COMPLETED Phase PHASE3
NCT00174967 Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout Status COMPLETED Phase PHASE2
NCT00174915 Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. Status COMPLETED Phase PHASE3
NCT00111657 Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout Status COMPLETED Phase PHASE2
NCT00102440 Febuxostat Versus Allopurinol Control Trial in Subjects With Gout Status COMPLETED Phase PHASE3
NCT00080210 A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy Status COMPLETED Phase PHASE2